El selenio es un elemento esencial en la nutrición humana.
Ha atraído un creciente interés científico en los últimos años por su potencial para prevenir el cáncer. El selenio esta presenta en múltiples formas
en la naturaleza, tres de los cuales son especialmente importantes en la
prevención de los cánceres humanos (sodium selenite, L-selenomethionine y
selenium-methyl L-selenocysteine). Cada una de estas tres formas de selenio ha
producido resultados interesantes. Los estudios en laboratorio revelan lo
siguiente: cada forma de selenio tiene un conjunto único de mecanismos, y cada
una afecta a los diferentes tipos de cáncer. El cuerpo humano maneja cada forma
de selenio en una forma diferente, y cada forma contribuye únicamente a la
prevención del cáncer que emerge. Sólo mediante la combinación de las tres
formas de selenio puede estar seguro de una optimización en la reducción del
riesgo de cáncer.
Beneficios adicionales del selenio
Además de proteger contra diversos tipos de cáncer, estudios
clínicos señalan que el selenio desempeña un papel en la prevención y el
tratamiento de una variedad notable de patologías, incluyendo:
La enfermedad cardio-vascular
Osteoartritis
La artritis reumatoide
Hipotiroidismo
Ictus
La aterosclerosis
La enfermedad de Alzheimer
La esclerosis lateral amiotrófica
Pancreatitis
La Depresión
Fuente natural de selenio : nueces de Brasil
Antes de tomar cualquier suplemento consulta su medico. No
se pretende aquí confirmar y expresar que selenio cura el cáncer, ni que se deje de tomar medicamentos. Solo informamos de que puede ser de su interés.
Fuentes:
Revista Life Extension "Selenium: What Forms Protect Against Cancer?" por Kirk Stokel
Fleet JC.
Dietary selenium repletion may reduce cancer incidence in people at high risk
who live in areas with low soil selenium. Nutr Rev. 1997 Jul;55(7):277-9.
Peters U,
Takata Y. Selenium and the prevention of prostate and colorectal cancer. Mol
Nutr Food Res. 2008 Nov;52(11):1261-72.
Mark SD,
Qiao YL, Dawsey SM, et al. Prospective study of serum selenium levels and
incident esophageal and gastric cancers. J Natl Cancer Inst. 2000 Nov
1;92(21):1753-63.
van den
Brandt PA, Goldbohm RA, van 't Veer P, et al. A prospective cohort study on
selenium status and the risk of lung cancer. Cancer Res. 1993 Oct
15;53(20):4860-5.
Helzlsouer
KJ, Comstock GW, Morris JS. Selenium, lycopene, alpha-tocopherol, beta-carotene,
retinol, and subsequent bladder cancer. Cancer Res. 1989 Nov 1;49(21):6144-8.
Taylor PR,
Qiao YL, Abnet CC, et al. Prospective study of serum vitamin E levels and
esophageal and gastric cancers. J Natl Cancer Inst. 2003 Sep 17;95(18):1414-6.
Lee EH, Myung SK,
Jeon YJ, et al. Effects of selenium supplements on cancer prevention:
Meta-analysis of randomized controlled trials. Nutr Cancer. 2011 Oct 17.
Yoshizawa
K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in
toenails and the risk of advanced prostate cancer. J Natl Cancer Inst. 1998 Aug
19;90(16):1219-24.
Ghadirian
P, Maisonneuve P, Perret C, et al. A case-control study of toenail selenium and
cancer of the breast, colon, and prostate. Cancer Detect Prev.
2000;24(4):305-13.
Willett WC,
Polk BF, Morris JS, et al. Prediagnostic serum selenium and risk of cancer. Lancet.
1983 Jul 16;2(8342):130-4.
Salonen JT,
Alfthan G, Huttunen JK, Puska P. Association between serum selenium and the
risk of cancer. Am J Epidemiol. 1984 Sep;120(3):342-9.
Glattre E,
Thomassen Y, Thoresen SO, et al. Prediagnostic serum selenium in a case-control
study of thyroid cancer. Int J Epidemiol. 1989 Mar;18(1):45-9.
Brozmanova
J. Selenium and cancer: from prevention to treatment. Klin Onkol. 2011;24(3):171-9.
Naithani R.
Organoselenium compounds in cancer chemoprevention. Mini Rev Med Chem. 2008
Jun;8(7):657-68.
Clark LC,
Combs GF, Jr., Turnbull BW, et al. Effects of selenium supplementation for
cancer prevention in patients with carcinoma of the skin. A randomized
controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996 Dec
25;276(24):1957-63.
Ganther HE.
Selenium metabolism, selenoproteins and mechanisms of cancer prevention:
complexities with thioredoxin reductase. Carcinogenesis. 1999
Sep;20(9):1657-66.
Rayman MP.
Selenium in cancer prevention: a review of the evidence and mechanism of
action. Proc Nutr Soc. 2005 Nov;64(4):527-42.
Klein EA,
Thompson IM, Jr., Tangen CM, et al. Vitamin E and the risk of prostate cancer:
the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct
12;306(14):1549-56.
Lippman SM,
Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of
prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention
Trial (SELECT). JAMA. 2009 Jan 7;301(1):39-51.
El-Bayoumy
K. The negative results of the SELECT study do not necessarily discredit the
selenium-cancer prevention hypothesis. Nutr Cancer. 2009;61(3):285-6.
Marshall
JR, Ip C, Romano K, et al. Methyl Selenocysteine: single-dose pharmacokinetics
in men. Cancer Prev Res (Phila). 2011 Aug 16.
Fleming J,
Ghose A, Harrison PR. Molecular mechanisms of cancer prevention by selenium
compounds. Nutr Cancer. 2001;40(1):42-9.
Sinha R,
El-Bayoumy K. Apoptosis is a critical cellular event in cancer chemoprevention
and chemotherapy by selenium compounds. Curr Cancer Drug Targets. 2004
Feb;4(1):13-28.
Fang MZ,
Zhang X, Zarbl H. Methylselenocysteine resets the rhythmic expression of
circadian and growth-regulatory genes disrupted by nitrosomethylurea in vivo. Cancer
Prev Res (Phila). 2010 May;3(5):640-52.
Bhattacharya
A. Methylselenocysteine: a promising antiangiogenic agent for overcoming drug
delivery barriers in solid malignancies for therapeutic synergy with anticancer
drugs. Expert Opin Drug Deliv. 2011 Jun;8(6):749-63.
Bhattacharya
A, Turowski SG, San Martin ID, et al. Magnetic resonance and
fluorescence-protein imaging of the anti-angiogenic and anti-tumor efficacy of
selenium in an orthotopic model of human colon cancer. Anticancer Res. 2011
Feb;31(2):387-93.
Spallholz
JE. Selenium and the prevention of cancer Part II: Mechanisms for the
carcinostatic activitiy of Se compounds. The Bulletin of Selenium-Tellurium
Development Association. 2001 October;October 2001:12.
Brozmanova
J, Manikova D, Vlckova V, Chovanec M. Selenium: a double-edged sword for defense
and offence in cancer. Arch Toxicol. 2010 Dec;84(12):919-38.
Mahn AV, Toledo HM, Ruz MH.
Organic and inorganic selenium compounds produce different protein patterns in
the blood plasma of rats. Biol Res. 2009;42(2):163-73.
Barger JL,
Kayo T, Pugh TD, et al. Gene expression profiling reveals differential effects
of sodium selenite, selenomethionine, and yeast-derived selenium in the mouse. Genes
Nutr. 2011 Aug 17.
Burk RF,
Norsworthy BK, Hill KE, Motley AK, Byrne DW. Effects of chemical form of selenium
on plasma biomarkers in a high-dose human supplementation trial. Cancer
Epidemiol Biomarkers Prev. 2006 Apr;15(4):804-10.
El-Sayed
WM, Aboul-Fadl T, Lamb JG, Roberts JC, Franklin MR. Effect of
selenium-containing compounds on hepatic chemoprotective enzymes in mice. Toxicology.
2006 Mar 15;220(2-3):179-88.
Suzuki M,
Endo M, Shinohara F, Echigo S, Rikiishi H. Differential apoptotic response of
human cancer cells to organoselenium compounds. Cancer Chemother Pharmacol.
2010 Aug;66(3):475-84.
Lunoe K,
Gabel-Jensen C, Sturup S, Andresen L, Skov S, Gammelgaard B. Investigation of
the selenium metabolism in cancer cell lines. Metallomics. 2011 Feb;3(2):162-8.
Broome CS,
McArdle F, Kyle JA, et al. An increase in selenium intake improves immune function
and poliovirus handling in adults with marginal selenium status. Am J Clin
Nutr. 2004 Jul;80(1):154-62.
Weekley CM,
Aitken JB, Vogt S, et al. Metabolism of selenite in human lung cancer cells:
X-ray absorption and fluorescence studies. J Am Chem Soc. 2011 Sep 28.
Chen XJ,
Duan FD, Zhang HH, Xiong Y, Wang J. Sodium selenite-induced apoptosis mediated
by ROS attack in human osteosarcoma U2OS cells. Biol Trace Elem Res.
2011 Aug 9.
Fu L, Liu
Q, Shen L, Wang Y. Proteomic study on sodium selenite-induced apoptosis of
human cervical cancer HeLa cells. J Trace Elem Med Biol. 2011
Jul;25(3):130-7.
